Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.4600
-0.0200 (-4.17%)
Sep 11, 2026, 10:19 AM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 104.88 million as of September 10, 2026. Its market cap has decreased by -12.39% in one year.
Market Cap
104.88M
Enterprise Value
67.76M
Revenue
3.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
ChartMarket Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 104.88M, an increase of 103.61%. That is a compound annual growth rate of 2.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 104.88M | 20.55% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 164.78M |
| Dimerix | 162.11M |
| Island Pharmaceuticals | 130.20M |
| Recce Pharmaceuticals | 113.13M |
| LTR Pharma | 87.25M |
| Avecho Biotechnology | 77.27M |
| Arovella Therapeutics | 72.53M |
| Immutep | 69.26M |